After correction of CFTR locus by CRISPR–cas9, it was found out that corrected gene not only expressed but also fully functional, as CFTR locus retain its ability of cAMP-induced intestinal stem cell organoid swelling, that is lost in CFTR-mutated cystic fibrosis patients. Here, CFTR is linked to cystic fibrosis.